Upgrade to SI Premium - Free Trial

Compass Pathways (CMPS) PT Raised to $17 at Morgan Stanley

May 14, 2026 8:52 AM
Morgan Stanley analyst Judah C. Frommer raised the price target on Compass Pathways (NASDAQ: CMPS) to $17.00 (from $16.00) while maintaining a Overweight rating.

Categories

Analyst PT Change